Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-04

Clinical Trial Update: Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the mechanism of action of fluticasone furoate in children with obstructive sleep apnea syndrome. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Furoate (fluticasone furoate)

Snippet

Sponsor: University of Chicago | Conditions: Childhood Obstructive Sleep Apnea Syndrome (OSAS) | Phase 4 | Status: COMPLETED | Results posted: 2015-05-04